[Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
Efficacy and tolerability of perorally administered desmopressin were evaluated in 12 adult patients suffering from central diabetes insipidus. According to the results of the study desmopressin should be administered at a higher dosage than 300 micrograms/die to obtain the same antidiuretic effect as with the intranasal administration. No significant changes in body weight, arterial pressure and blood chemistry parameters have been detected over the whole administration period and only some slight side-effects occurred. Oral desmopressin may be considered as an effective alternative to traditional intranasal administration and it may significantly improve patients' compliance.
Rampazzo
A L
AL
Istituto di Semeiotica, Università degli Studi di Padova.
Boscaro
M
M
Mantero
F
F
Piccitto
R
R
D000281:Administration, Intranasal; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage* / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D012996:Solutions; D013607:Tablets
D012996:Solutions; D013607:Tablets; D003894:Deamino Arginine Vasopressin
Valutazione clinica della desmopressina (DDAVP) nel diabete insipido: soluzione vs compresse.